Factors Associated With Diabetes Distress Among Patients With Poorly Controlled Type 2 Diabetes

Jashalynn German, Elizabeth A Kobe, Allison A Lewinski, Amy S Jeffreys, Cynthia Coffman, David Edelman, Bryan C Batch, Matthew J Crowley, Jashalynn German, Elizabeth A Kobe, Allison A Lewinski, Amy S Jeffreys, Cynthia Coffman, David Edelman, Bryan C Batch, Matthew J Crowley

Abstract

Objective: Examine factors associated with increased diabetes distress (DD) among patients with type 2 diabetes with DD assessed by Diabetes Distress Scale (DDS) total and subscale scores (emotional burden, physician-related distress, regimen-related distress, and interpersonal distress).

Methods: Cross-sectional analysis of data from veterans with persistently poorly controlled diabetes mellitus. Multivariable linear regression models included baseline patient characteristics (independent variables) and DDS total and subscale scores (dependent variable).

Results: The cohort's (N = 248) mean age was 58 years (SD 8.3); 21% were female, 79% were non-White, and 5% were Hispanic/Latinx. Mean hemoglobin A1c (HbA1c) was 9.8%, and 37.5% had moderate to high DD. Hispanic/Latinx ethnicity (β=0.41; 95% CI 0.01, 0.80), baseline HbA1c (0.07; 95% CI 0.01,0.13), and higher Personal Health Questionnaire-8 (PHQ-8) scores (0.07; 95% CI 0.05, 0.09) were associated with higher total DD. Hispanic/Latinx ethnicity (0.79; 95% CI 0.25, 1.34) and higher PHQ-8 (0.05; 95% CI 0.03, 0.08) were associated with higher interpersonal-related distress. Higher HbA1c (0.15; 95% CI 0.06, 0.23) and higher PHQ-8 scores (0.10; 95% CI 0.07, 0.13) were associated with higher regimen-related distress. The use of basal insulin (0.28; 95% CI 0.001, 0.56) and higher PHQ-8 (0.02; 95% CI 0.001, 0.05) were associated with higher physician-related distress. Higher PHQ-8 (0.10; 95% CI 0.07, 0.12) was associated with higher emotional burden.

Conclusion: Hispanic/Latinx ethnicity, depressive symptoms, uncontrolled hyperglycemia, and insulin use were associated with higher risk for DD. Future research should explore these relationships, and interventions designed to reduce diabetes distress should consider accounting for these factors.

Keywords: T2DM; Veterans Affairs medical center; diabetes distress; disparities; poorly controlled diabetes; type 2 diabetes.

Published by Oxford University Press on behalf of the Endocrine Society 2023.

References

    1. US Department of Health and Human Services . National diabetes statistics report; 2020.
    1. Lin J, Thompson TJ, Cheng YJ, et al. . Projection of the future diabetes burden in the United States through 2060. Popul Health Metr. 2018;16(1):9. doi:10.1186/s12963-018-0166-4
    1. American Diabetes Association . Economic costs of diabetes in the U. S. in 2017. Diabetes Care. 2018;41(5):917–928. 10.2337/dci18-0007
    1. Gonzalez JS, Fisher L, Polonsky WH. Depression in diabetes: have we been missing something important? Diabetes Care. 2011;34(1):236–239. doi:10.2337/dc10-1970
    1. Gahlan D, Rajput R, Gehlawat P, Gupta R. Prevalence and determinants of diabetes distress in patients of diabetes mellitus in a tertiary care centre. Diabetes Metab Syndr. 2018;12(3):333–336. doi:10.1016/j.dsx.2017.12.024
    1. Gonzalez JS, Kane NS, Binko DH, Shapira A, Hoogendoorn CJ. Tangled up in blue: unraveling the links between emotional distress and treatment adherence in type 2 diabetes. Diabetes Care. 2016;39(12):2182–2189. doi:10.2337/dc16-1657
    1. Polonsky WH, Fisher L, Earles J, et al. . Assessing psychosocial distress in diabetes: development of the Diabetes Distress Scale. Diabetes Care. 2005;28(3):626–631. doi:10.2337/diacare.28.3.626
    1. Gonzalez JS, Shreck E, Psaros C, Safren SA. Distress and type 2 diabetes-treatment adherence: a mediating role for perceived control. Health Psychol. 2015;34(5):505–513. 10.1037/hea0000131
    1. Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012;35(2):259–264. doi:10.2337/dc11-1572
    1. Stratton IM, Adler AI, Neil HA, et al. . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405
    1. Engelgau MM, Geiss LS, Saaddine JB, et al. . The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945–950. doi:10.7326/0003-4819-140-11-200406010-00035
    1. Centers for Disease Control and Prevention . Hispanic or Latino people and type 2 diabetes. 2022.
    1. Crowley MJ, Holleman R, Klamerus ML, Bosworth HB, Edelman D, Heisler M. Factors associated with persistent poorly controlled diabetes mellitus: clues to improving management in patients with resistant poor control. Chronic Illn. 2014;10(4):291–302. doi:10.1177/1742395314523653
    1. Crowley MJ, Edelman D, McAndrew AT, et al. . Practical telemedicine for veterans with persistently poor diabetes control: a randomized pilot trial. Telemed J E Health. 2016;22(5):376–384. doi:10.1089/tmj.2015.0145
    1. Mata-Cases M, Rodríguez-Sanchez B, Mauricio D, et al. . The association between poor glycemic control and health care costs in people with diabetes: a population-based study. Diabetes Care. 2020;43(4):751–758. doi:10.2337/dc19-0573
    1. Alexopoulos AS, Jackson GL, Edelman D, et al. . Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: a nationwide cohort study. PLoS One. 2019;14(3):e0214679.doi:10.1371/journal.pone.0214679
    1. Pintaudi B, Lucisano G, Gentile S, et al. . Correlates of diabetes-related distress in type 2 diabetes: findings from the benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study. J Psychosom Res. 2015;79(5):348–354. doi:10.1016/j.jpsychores.2015.08.010
    1. American Diabetes Association Professional Practice Committee, Draznin B, Aroda VR, et al. . 5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2022. Diabetes Care. 2022; 45(Suppl_1):S60–S82. doi:10.2337/dc22-S005
    1. Johansen C, Torenholt R, Hommel E, Wittrup M, Cleal B, Willaing I. Barriers to addressing psychological problems in diabetes: perspectives of diabetologists on routine diabetes consultations in Denmark. J Psychol Psychother. 2014;4(2):141. doi:10.4172/2161-0487.1000141
    1. Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med. 2019;34(2):320–324. doi:10.4172/2161-0487.1000141
    1. Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2017;34(11):1508–1520. doi:10.1111/dme.13448
    1. Kobe EA, Edelman D, Tarkington PE, et al. . Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): protocol and baseline data for a randomized trial. Contemp Clin Trials. 2020;98:106157. doi:10.1016/j.cct.2020.106157
    1. Diabetes Distress Assessment & Resource Center . The DDS assesses diabetes distress for adults with type 2 diabetes. Accessed April 3, 2022.
    1. US Department of Veteran Affairs . National Center for Veterans analysis and statistics. Updated September 2022. Accessed November 2022.
    1. Andersen JA, Scoggins D, Michaud T, Wan N, Wen M, Su D. Racial disparities in diabetes management outcomes: evidence from a remote patient monitoring program for type 2 diabetic patients. Telemed J E Health. 2021;27(1):55–61. doi:10.1089/tmj.2019.0280
    1. Baek RN, Tanenbaum ML, Gonzalez JS. Diabetes burden and diabetes distress: the buffering effect of social support. Ann Behav Med. 2014;48(2):145–155. 10.1007/s12160-013-9585-4
    1. Carper MM, Traeger L, Gonzalez JS, Wexler DJ, Psaros C, Safren SA. The differential associations of depression and diabetes distress with quality of life domains in type 2 diabetes. J Behav Med. 2014;37(3):501–510. doi:10.1007/s10865-013-9505-x
    1. Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care. 2010;33(5):1034–1036. doi:10.2337/dc09-2175
    1. McEwen MM, Pasvogel A, Gallegos G, Barrera L. Type 2 diabetes self-management social support intervention at the U.S.-Mexico border. Public Health Nurs. 2010;27(4):310–319. doi:10.1111/j.1525-1446.2010.00860.x
    1. Park H, Park C, Quinn L, Fritschi C. Glucose control and fatigue in type 2 diabetes: the mediating roles of diabetes symptoms and distress. J Adv Nurs. 2015;71(7):1650–1660. doi:10.1111/jan.12632
    1. Smith KJ, Gariépy G, Pedneault M, Beland M, Clyde M, Schmitz N. Exploring the association of psychological status with self-rated diabetes control: results from the Montreal evaluation of diabetes treatment study. Psychosomatics. 2013;54(1):35–43. doi:10.1016/j.psym.2012.08.002
    1. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31(7):764–772. doi:10.1111/dme.12428
    1. Fisher L, Polonsky WH, Hessler D. Addressing diabetes distress in clinical care: a practical guide. Diabet Med. 2019;36(7):803–812. doi:10.1111/dme.13967
    1. Hendrieckx C, Halliday JA, Beeney LJ, Speight J. Diabetes and Emotional Health: A Practical Guide for Health Professionals Supporting Adults With Type 1 or Type 2 Diabetes. 3rd ed. American Diabetes Association;2021.
    1. Spencer MS, Kieffer EC, Sinco BR, et al. . Diabetes-specific emotional distress among African Americans and Hispanics with type 2 diabetes. J Health Care Poor Underserved. 2006:17(2S):88–105. doi:10.1353/hpu.2006.0095
    1. Cohen S. Social relationships and health. Am Psychol. 2004;59(8):676–684. doi:10.1037/0003-066X.59.8.676
    1. Campos B, Kim HS. Incorporating the cultural diversity of family and close relationships into the study of health. Am Psychol. 2017;72(6):543–554. doi:10.1037/amp0000122
    1. Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312. doi:10.1016/S0140-6736(18)31948-2
    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–1078. doi:10.2337/diacare.24.6.1069
    1. Kangethe A, Lawrence DF, Touya M, Chrones L, Polson M, Evangelatos T. Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis. BMC Health Serv Res. 2021;21(1):778. doi:10.1186/s12913-021-06802-9
    1. Depression. Centers for Disease Control and Prevention/National Center for Health Statistics . Depression. Updated March 25, 2022. Accessed May 2022.
    1. Ratnesh SK, Kannan S, Khadilkar KS, Sravani GV, Raju R. Identifying the burden and predictors of diabetes distress among adult type 2 diabetes Mellitus patients. Indian J Community Med. 2020;45(4):497–500. doi:10.4103/ijcm.IJCM_533_19
    1. Yoshioka N, Ishii H, Tajima N, Iwamoto Y;DAWN Japan Group . Differences in physician and patient perceptions about insulin therapy for management of type 2 diabetes: the DAWN Japan study. Curr Med Res Opin. 2014;30(2):177–183. doi:10.1185/03007995.2013.855187
    1. Kerr EA, Heisler M, Krein SL, et al. . Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients’ treatment priorities and self-management? J Gen Intern Med. 2007;22(12):1635–1640. doi:10.1007/s11606-007-0313-2
    1. Office of Health Equity . Racial and ethnic minority veterans. Updated July 2020. Accessed November 2022.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться